Professor Emmanuel Tsochatzis, MD, MSc, FEBTM, FRCP, PhD, is Professor of Hepatology at University College London and Consultant Hepatologist at the Royal Free Hospital, where he leads the Centre for Metabolic Liver Disease and the specialist multidisciplinary service for MASLD.

His research focuses on MASLD, non-invasive assessment of liver fibrosis, cirrhosis and portal hypertension, and Wilson’s disease. He developed and implemented a two-step primary care referral pathway for MASLD based on non-invasive fibrosis assessment, which has informed the approach to fibrosis risk stratification adopted by all major international MASLD guidelines. His work on the cost-effectiveness of non-invasive fibrosis tests has also informed World Health Organization guidelines for the diagnosis and treatment of hepatitis B and C.

Professor Tsochatzis is a member of the Baveno Steering Committee and previously served on the EASL Governing Board (2019–2022), including as Chair of the EASL Scientific Committee (2021–2022). He is an Associate Editor of Clinical Gastroenterology and Hepatology and a recipient of the UEG Rising Star Award and EASL Physician Scientist Fellowship.

He has authored more than 400 peer-reviewed publications, with research funding from the NIHR, MRC, EASL and EU Horizon 2020.